| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Johnson David Michael serves as a Director at ZNTL and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 8 sells.
Historically, Johnson David Michael's trades have earned a middling insider score of 59/100 across 14 rated trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of +1.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | AURA Aura Biosciences, Inc. | Director | Buy | 20,000 | $4.90 | $98,000.00 | +13.7% | +17.6% | +30.1% | |
| Nov 10, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Buy | 17,000 | $9.88 | $167,943.00 | +13.3% | +17.3% | -59.8% | |
| Nov 8, 2023 | AURA Aura Biosciences, Inc. | Director | Buy | 199,601 | $7.19 | $1,434,987.30 | -160.2% | +11.3% | +48.9% | |
| Oct 4, 2023 | AURA Aura Biosciences, Inc. | Director | Buy | 20,066 | $8.38 | $168,174.80 | +66.9% | +3.9% | +0.5% | |
| Jan 6, 2023 | AURA Aura Biosciences, Inc. | Director | Buy | 2,000 | $10.41 | $20,811.04 | +12.5% | -17.8% | -15.7% | |
| Dec 28, 2022 | AURA Aura Biosciences, Inc. | Director | Buy | 4,000 | $9.75 | $39,000.00 | +30.8% | -6.4% | -8.3% | |
| Dec 1, 2022 | AURA Aura Biosciences, Inc. | Director | Buy | 10,000 | $12.37 | $123,700.00 | +200.0% | -24.7% | -39.0% | |
| Jun 13, 2022 | AURA Aura Biosciences, Inc. | Director | Buy | 50,000 | $14.33 | $716,300.00 | -250.0% | +29.1% | -6.1% | |
| Oct 4, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 12,896 | $66.35 | $855,588.31 | -13.7% | +20.9% | -66.8% | |
| Apr 5, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 12,897 | $43.50 | $561,020.79 | -12.7% | +7.0% | +12.5% |